Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

por Courvoisier, D.S., Alpizar-Rodriguez, D., Gottenberg, J.E., Hernandez, M.V., Iannone, F., Lie, E., Santos, M.J., Pavelka, K., Turesson, C., Mariette, X., Choquette, D., Hetland, M.L., Finckh, A.
Publicado 2016

A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population

por Raynauld, J-P, Martel-Pelletier, J, Berthiaume, M-J, Beaudoin, G, Labonté, F, Bloch, DA, Choquette, D, Haraoui, B, Altman, RD, Hochberg, M, Beary, J, Cline, G, Meyer, J, Valent, DJ, Pelletier, J-P
Publicado 2004

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, co...

por Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Publicado 2015